对于波兰帕金森病患者的设备辅助疗法的可用性
Katarzyna Smilowska1,2, Tomasz Pietrzykowski3, K Ray Chaudhuri4,5
1Department of Neurology, 5th Regional Hospital, Sosnowiec, Poland.
Journal of movement disorders
|November 19, 2023
概括
获得对帕金森病的设备辅助疗法 (DAT).
科学领域:
- 神经学 神经学
- 医疗器械可访问性 医疗器械可访问性
- 公共卫生 公共卫生
背景情况:
- 帕金森病 (PD) 管理通常涉及先进的设备辅助疗法 (DAT).
- 公平获得这些关键治疗是全球和波兰国内的一个重大挑战.
- 了解DAT分布对于改善患者护理至关重要.
研究的目的:
- 分析波兰帕金森病 (PD) 患者的设备辅助疗法 (DAT) 的可获得性和分布情况.
- 调查DAT使用的区域差异.
- 检查影响DAT可访问性的因素.
主要方法:
- 分析2015年至2021年波兰的DAT使用数据 (深度大脑刺激,腹腔内利沃多巴,阿波莫尔芬).
- 计算PD患者接受DAT的百分比.
- 统计分析以确定可访问性与社会经济因素之间的关联.
主要成果:
- 波兰的DAT使用率从2015年的0.21%增加到2021年的0.56%.
- 深度大脑刺激是最常见的DAT,但在其他DAT中发现了显著的区域差异.
- 较低的平均年收入与DAT可访问性有负相关性 (p < 0.001).
结论:
- 波兰帕金森病患者使用DAT的机会仍然有限.
- 在DAT可访问性方面,仍然存在显著的区域差异.
- 虽然总体上获得的机会增加了,但需要有针对性的干预措施来解决不平等问题.
相关概念视频
01:24Parkinson's Disease: Treatment
278
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
278
01:15Parkinson's Disease: Overview
560
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
560